Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

UDL Laboratories, Inc. Recalls Single Lot of Levothyroxine Sodium Tablets, 150 mcg
UDL Laboratories Inc. has recalled a single lot of Levothyroxine Sodium Tablets, 150 mcg sold in blister packs. Lot number OA432 has been recalled because routine testing found that the amount of active ingredient was too low in several samples from this lot. Levothyroxine is used in the treatment of thyroid disorders. Levothyroxine is also sold under the brand names Levo-T, Levoxyl, Levothroid, Synthroid, Tirosint, and Unithroid. No other lots, strengths, or brands of Levothyroxine were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm252912.htm
Learn More

Teva Recalls Single Lot of Chlorzoxazone Tablets, 500 mg
Teva Pharmaceuticals USA has recalled a single lot of Chlorzoxazone Tablets, 500 mg. Lot number 314134 is being recalled because the bottles in this lot were found to contain residue of another medication called isoniazid, an antibiotic commonly used to treat tuberculosis. Chlorzoxazone is used in the treatment of muscle pains and strains. Chlorzoxazone is also known by the brand names Eze D.S., Paraflex, Parafon Forte DSC, Relax-DS, Relaxazone, Remular, Remular-S, and Strifon Fort. No other lots, strengths, or brands of Chlorzoxazone were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm252912.htm
Learn More

Date Published Title Drug Source
2011-05-02 UDL Laboratories, Inc. Recalls Single Lot of Levothyroxine Sodium Tablets, 150 mcg Levothyroxine FDA
2011-05-02 Teva Recalls Single Lot of Chlorzoxazone Tablets, 500 mg Chlorzoxazone FDA
2011-04-29 FDA Drug Safety Communication: Safety Review Update of Benicar (olmesartan) and the Risk of Heart Attack, Sudden Death, and Stroke Olmesartan and Hydrochlorothiazide FDA
2011-04-29 New Study: Too High a Dose of Thyroid Drug Raises Fracture Risk in Older Adults Levothyroxine MediGuard CRT
2011-04-26 More Research Needed to Confirm Recent Study Results Showing That Anti-inflammatory Pain Medicines May Dampen Effect of Selective Serotonin Re-uptake Inhibitors (SSRIs) Paroxetine MediGuard CRT
2011-04-25 Mylan Pharmaceuticals Inc. Recalls Several Lots of Metformin Metformin FDA
2011-04-25 GlaxoSmithKline Inc. Recalls Select Lots of DynaCirc CR (isradipine) Controlled Release Tablets, 5 mg Isradipine FDA
2011-04-25 Teva Pharmaceuticals USA, Inc. Recalls Select Lots of Topiramate Tablets, 25 mg Topiramate FDA
2011-04-25 Abbott Laboratories Recalls Several Lots of CREON (pancrelipase) Delayed Release Capsules, 6000 USP units Creon 20 FDA
2011-04-25 Lupin Pharmaceuticals Recalls Single Lot of Lisinopril Tablets, 30 mg Lisinopril FDA
2011-04-25 Centocor Ortho Biotech Recalls Single Lot of Simponi (golimumab), 50 mg/0.5 mL Golimumab FDA
2011-04-25 Teva Pharmaceuticals Recalls Single Lot of Gemfibrozil tablets, 600 mg Gemfibrozil FDA
2011-04-25 Novartis Pharmaceuticals Recalls Single Lot of Diovan (Valsartan) 160 mg Valsartan FDA
2011-04-25 Teva Pharmaceuticals Recalls Single Lot of Carvedilol Tablets, 12.5 mg Carvedilol FDA
2011-04-25 Teva Pharmaceuticals Recalls Three Lots of Pravastatin Sodium Tablets 20 mg and 40 mg Pravastatin FDA
2011-04-25 Teva Pharmaceuticals Recalls Single Lot of Zolpidem Tartrate tablets Zolpidem FDA
2011-04-25 Clot Risk May Be Higher With Newer Birth Control Pills Drospirenone with Ethinyl Estradiol MediGuard CRT
2011-04-25 FDA Issues Update on the Risk Of Progressive Multifocal Leukoencephalopathy With Tysabri Natalizumab FDA
2011-04-20 FDA Announces New Program for Long-Acting and Extended-Release Opioids Methadone FDA
2011-04-19 Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Can Clog, Block Oral Syringes and Feeding Tubes Lansoprazole FDA
Back to Consumer Med Safety